Skip to Main Content

Author Details

Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
2004
211
40
PMIDPaper TitleJournal TitlePublished Year
37611810The Auto-Lindberg Project: Standardized Target Nomenclature in Radiation Oncology Enables Real-World Data Extraction From Radiation Treatment Plans.Int J Radiat Oncol Biol Phys2024
37751180Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma.Cancer2024
36348098The role of HPV status in patients with overlapping grey zone cancer in oral cavity and oropharynx.Eur Arch Otorhinolaryngol2023
37799466Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis.Front Oncol2023
37486534HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck Pathology.Head Neck Pathol2023
37478572The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A Canadian sarcoma research and Clinical Collaboration (CanSaRCC) study.Oral Oncol2023
37499325Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients.Oral Oncol2023
37498564Individualized risk assessment of distant metastases in oral cavity carcinoma: a validated predictive-score model.J Natl Cancer Inst2023
37453792The Interplay Between Radiation Dose, Volume, and Systemic Therapy.Int J Radiat Oncol Biol Phys2023
36948414Effect of Radiation Therapy Quality Assurance on Nasopharyngeal Carcinoma: Usage of a Novel, Web-Based Quality Assurance Application.Pract Radiat Oncol2023
37243515Associations between Human Papillomavirus Status, Weight Change, and Survival of Oropharyngeal Cancer Patients.Nutr Cancer2023
37397861Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics.Cancer Res Commun2023
36480193Association of Primary Tumor Volume With Survival in Patients With T3 Glottic Cancer Treated With Radiotherapy: A Study of the Canadian Head & Neck Collaborative Research Initiative.JAMA Otolaryngol Head Neck Surg2023
36653915Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.Cancer2023
36694401A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers.Int J Cancer2023
36811599Proliferative exhausted CD8<sup>+</sup> T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma.Elife2023
36780824The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis.Oral Oncol2023
36746459Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.BMJ2023
36912224Are we ready for deintensification in human papillomavirus-positive oropharyngeal carcinomas?Curr Opin Otolaryngol Head Neck Surg2023
36796393Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.Lancet Oncol2023
36416855Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer.JAMA Otolaryngol Head Neck Surg2023
34597435Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.Cancer2022
35804877Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up.Cancers (Basel)2022
35801270Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer.Head Neck2022
35766141Augmenting inter-rater concordance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma: A multicenter study.Head Neck2022
35454830An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.Cancers (Basel)2022
35588085Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.Cancer2022
36397659Dynamic changes of hematological indices in oropharyngeal cancer patients treated with radiotherapy.Acta Otolaryngol2022
35905781Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary.Radiother Oncol2022
35997729Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.JAMA2022
36353565Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma.Front Oncol2022
36010888Oligometastatic Head and Neck Cancer: Challenges and Perspectives.Cancers (Basel)2022
35315548Radiologic-pathologic correlation of major versus minor extranodal extension in oral cavity cancer.Head Neck2022
35038657Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma.Oral Oncol2022
35121396Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.Oral Oncol2022
34971660Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial.Radiother Oncol2022
35305091Unfinished Business in Classifying HPV-Positive Oropharyngeal Carcinoma: Identifying the Bad Apples in a Good Staging Barrel.Oncologist2022
35238880Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.JAMA Otolaryngol Head Neck Surg2022
34792199Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.Int J Cancer2022
32761517Pre-treatment psychoeducational intervention and outcomes in head and neck cancer patients undergoing radiotherapy.Support Care Cancer2021
33600871Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy.Radiother Oncol2021
33508706Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma.Oral Oncol2021
33532634Statistical fundamentals on cancer research for clinicians: Working with your statisticians.Clin Transl Radiat Oncol2021
33580567Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy.Head Neck2021
33524796Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey.Oral Oncol2021
33856051Importance of Margins, Radiotherapy, and Systemic Therapy in Mucosal Melanoma of the Head and Neck.Laryngoscope2021
34540670Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature.Front Oncol2021
34718052Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort.Radiother Oncol2021
34834585Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study.J Pers Med2021
34158359Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res2021
  • 1 - 50 of 211

Recommended Authors

University of Western Ontario
Career Start Year 2018
Number of shared co-authors 3
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 13
Medical College of Wisconsin
Career Start Year 2013
Number of shared co-authors 4
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 8
Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 7
Moores Cancer Center, University of California
Career Start Year 2012
Number of shared co-authors 3
university of california san diego
Career Start Year 2010
Number of shared co-authors 2
University of Washington
Career Start Year 2009
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 9
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 2
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 2
University of Tokyo
Career Start Year 2005
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 11
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 20
Tokai University
Career Start Year 2002
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 16
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 7
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 9
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 9
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 10
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 13
University of Pittsburgh School of Medicine
Career Start Year 1997
Number of shared co-authors 10
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 7
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 11
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 10
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 11

Collaborators

Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 136
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 100
Princess Margaret Cancer Centre
Co-authored papers 99
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 75
Princess Margaret Cancer Centre
Co-authored papers 41
Princess Margaret Cancer Center
Co-authored papers 37
University Health Network
Co-authored papers 37
University Health Network
Co-authored papers 34
Princess Margaret Cancer Centre
Co-authored papers 27
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 26
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 26
Princess Margaret Cancer Centre, University Ave
Co-authored papers 15
Stanford University
Co-authored papers 10
Research Institute, Princess Margaret Cancer Centre
Co-authored papers 9
Princess Margaret Cancer Centre
Co-authored papers 6
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
University Health Network
Co-authored papers 5
Maastricht University Medical Centre
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Harvard Medical School
Co-authored papers 4
Qingpu Branch of Zhongshan Hospital, Fudan University
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Zhabei Central Hospital
Co-authored papers 4
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Margaret Cancer Center
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 3